JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+3.12%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$69.1M
AUM Growth
+$69.1M
(-12%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-17.1%
Top 10 Holdings %
Top 10 Hldgs %
98.45%
Holding
41
New
–
Increased
5
Reduced
8
Closed
26
Top Buys
| 1 |
Kraft Heinz
KHC
|
$43.2M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$468K |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$174K |
| 4 |
Incyte
INCY
|
$56.9K |
| 5 |
Neurocrine Biosciences
NBIX
|
$49.4K |
Top Sells
| 1 |
AB InBev
BUD
|
$18.7M |
| 2 |
Carter's
CRI
|
$12.3M |
| 3 |
Rio Tinto
RIO
|
$3.74M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$2.08M |
| 5 |
CVS Health
CVS
|
$1.91M |
Sector Composition
| 1 | Consumer Staples | 84.02% |
| 2 | Healthcare | 15.98% |
| 3 | Communication Services | 0% |
| 4 | Materials | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Kraft Heinz
KHC
$33.1B
| $46M | 38.24% |
506,888
+476,250
| +1,554% | +$43.2M |
|
|
2
AB InBev
BUD
$122B
| $12M | 10% |
109,700
-170,149
| -61% | -$18.7M |
|
|
3
Incyte
INCY
$16.5B
| $2.03M | 1.69% |
15,188
+426
| +3% | +$56.9K |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.9M | 1.58% |
21,624
+5,328
| +33% | +$468K |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $1.76M | 1.46% |
14,131
-4,160
| -23% | -$518K |
|
6
UnitedHealth
UNH
$281B
| $1.6M | 1.33% |
9,772
-2,437
| -20% | -$400K |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.12M | 0.93% |
9,245
-4,736
| -34% | -$574K |
|
8
Eli Lilly
LLY
$657B
| $670K | 0.56% |
7,969
-1,520
| -16% | -$128K |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $457K | 0.38% |
1,179
-1,943
| -62% | -$753K |
|
|
TSRO
10
DELISTED
TESARO, Inc.
TSRO
| $440K | 0.37% |
2,860
+1,133
| +66% | +$174K |
|
|
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
| $404K | 0.34% |
6,433
-15,612
| -71% | -$980K |
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $365K | 0.3% |
3,339
-1,660
| -33% | -$181K |
|
|
13
Neurocrine Biosciences
NBIX
$13.8B
| $299K | 0.25% |
6,903
+1,140
| +20% | +$49.4K |
|
|
14
Alphabet (Google) Class C
GOOG
$2.58T
| – | – |
-2,689
| Closed | -$2.08M |
|
15
Apple
AAPL
$3.45T
| – | – |
-4,569
| Closed | -$529K |
|
16
AbbVie
ABBV
$372B
| – | – |
-20,030
| Closed | -$1.25M |
|
17
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – |
-28,913
| Closed | -$834K |
|
18
Amgen
AMGN
$155B
| – | – |
-6,833
| Closed | -$999K |
|
19
Bath & Body Works
BBWI
$6.18B
| – | – |
-3,818
| Closed | -$251K |
|
20
Biogen
BIIB
$19.4B
| – | – |
-3,312
| Closed | -$939K |
|
21
Booking.com
BKNG
$181B
| – | – |
-274
| Closed | -$402K |
|
|
22
Carter's
CRI
$1.04B
| – | – |
-142,391
| Closed | -$12.3M |
|
|
23
CVS Health
CVS
$92.8B
| – | – |
-24,162
| Closed | -$1.91M |
|
|
DBVT
24
DBV Technologies
DBVT
$264M
| – | – |
-7,728
| Closed | -$271K |
|
25
iShares MSCI Brazil ETF
EWZ
$5.45B
| – | – |
0
| – | – |
|